Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yu. N. Polyanskaya
Up to Date Antiplatelet Therapy in Patients With High Risk of Thrombotic Events and Real Clinical Practice
Rational Pharmacotherapy in Cardiology
Cardiovascular Medicine
Pharmacology
Cardiology
Modern Antiplatelet Therapy of Ischemic Heart Disease Patients With High Risk of Thrombotic Events: Data From Evidence-Based Medicine and Real Practice
Rational Pharmacotherapy in Cardiology
Cardiovascular Medicine
Pharmacology
Cardiology
Related publications
Combination Therapy of High-Risk Patients in Real Clinical Practice. Results of Synergy Study. Part 1. Antihypertensive Branch
Rational Pharmacotherapy in Cardiology
Cardiovascular Medicine
Pharmacology
Cardiology
Atrial Fibrillation in Patient With High Thrombotic Risk: Which Therapy?
AboutOpen
Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study)
Rational Pharmacotherapy in Cardiology
Cardiovascular Medicine
Pharmacology
Cardiology
Optimizing Antiplatelet Therapy in High-Risk Patients With Atrial Fibrillation: Insights From Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Features and Main Problems of Treating Patients With High and Very High Cardiovascular Risk With Statins in Real Clinical Practice (According to the Data of the “PRIORITET” Research)
Cardiovascular Therapy and Prevention (Russian Federation)
Cardiovascular Medicine
Cardiology
Dual Antiplatelet Therapy After Stenting in All-Comers, ACS Patients and in High Bleeding Risk
Application of Antiplatelet and Angioprotective Therapy in Patients With Placental Insufficiency Development Risk Factors
Medical Council
Dual Antiplatelet or Dual Antithrombotic Therapy for Secondary Prevention in High-Risk Patients With Stable Coronary Artery Disease?
Thrombosis and Haemostasis
Hematology
